Muscle cells injections fall short in "encouraging" heart trial
This article was originally published in Clinica
Executive Summary
A trial to investigate the merits of implanting muscle cells in the heart as a treatment for heart failure (HF) has missed its goal, but has, nonetheless, yielded encouraging safety and secondary outcomes.